Literature DB >> 25624328

In vitro assessment of dual drug combinations to inhibit growth of Neisseria gonorrhoeae.

Kevin Pettus1, Samera Sharpe1, John R Papp2.   

Abstract

The development of resistance to first-line antimicrobial therapies has led to recommendations for combination therapies for the treatment of gonorrhea infection. Recent studies have shown the success of combination therapies in treating patients, but few have reported on the in vitro activities of these drug combinations. An in vitro assessment of azithromycin in combination with gentamicin demonstrated inhibition of growth and suggests that clinical trials may be warranted to assess the utility of this combination in treating gonorrhea infections.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25624328      PMCID: PMC4356837          DOI: 10.1128/AAC.04127-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Synergy, antagonism, and what the chequerboard puts between them.

Authors:  F C Odds
Journal:  J Antimicrob Chemother       Date:  2003-06-12       Impact factor: 5.790

2.  Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-08-10       Impact factor: 17.586

Review 3.  Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea.

Authors:  Magnus Unemo; Robert A Nicholas
Journal:  Future Microbiol       Date:  2012-12       Impact factor: 3.165

4.  In vitro synergy testing of novel antimicrobial combination therapies against Neisseria gonorrhoeae.

Authors:  Lindley A Barbee; Olusegun O Soge; King K Holmes; Matthew R Golden
Journal:  J Antimicrob Chemother       Date:  2014-01-26       Impact factor: 5.790

Review 5.  The use of cephalosporins for gonorrhea: the impending problem of resistance.

Authors:  Pennan M Barry; Jeffrey D Klausner
Journal:  Expert Opin Pharmacother       Date:  2009-03       Impact factor: 3.889

6.  The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea.

Authors:  Robert D Kirkcaldy; Hillard S Weinstock; Page C Moore; Susan S Philip; Harold C Wiesenfeld; John R Papp; Peter R Kerndt; Shacondra Johnson; Khalil G Ghanem; Edward W Hook
Journal:  Clin Infect Dis       Date:  2014-07-16       Impact factor: 9.079

  6 in total
  3 in total

1.  Endless Resistance. Endless Antibiotics?

Authors:  Jed F Fisher; Shahriar Mobashery
Journal:  Medchemcomm       Date:  2015-11-03       Impact factor: 3.597

Review 2.  Enhancing Whole Phage Therapy and Their Derived Antimicrobial Enzymes through Complex Formulation.

Authors:  Callum J Cooper; Shazeeda Koonjan; Anders S Nilsson
Journal:  Pharmaceuticals (Basel)       Date:  2018-04-19

Review 3.  Azithromycin resistant gonococci: a literature review.

Authors:  Awoke Derbie; Daniel Mekonnen; Yimtubezinash Woldeamanuel; Tamrat Abebe
Journal:  Antimicrob Resist Infect Control       Date:  2020-08-18       Impact factor: 4.887

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.